October 10, 2024
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Tyler Howes |
Re: | PaxMedica, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-282488 |
Dear Mr. Howes:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to October 15, 2024, at 5:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Harris Beach PLLC, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Scot Foley of Harris Beach PLLC at +1 (716) 200-5108.
Sincerely, | |
PAXMEDICA, INC. | |
/s/ Howard Weisman | |
Howard Weisman | |
Chief Executive Officer |
cc: | Scot Foley, Harris Beach PLLC |